{"filing":{"accession_number":"0001683168-26-007007","cik":"0001355790","ticker":"ISCO","company_name":"International Stem Cell CORP","form":"8-K","filing_date":"2026-09-08","report_date":"2026-09-01","primary_document":"intlstemcell_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1355790/000168316826007007/intlstemcell_8k.htm"},"events":[{"id":31944,"run_id":29340,"accession_number":"0001683168-26-007007","anchor_item_number":"2.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"International Stem Cell Corporation completed the sale of 100% of the membership interests of its wholly-owned subsidiary Lifeline Cell Technology, LLC to American Type Culture Collection, Inc. on September 1, 2026, for an adjusted purchase price of $25,250,000. This is a material disposition of a significant asset (a wholly-owned subsidiary) that would substantially affect the registrant's financial position and operations going forward, as evidenced by the pro forma financial statements showing elimination of LCT's substantial revenues and operations.","company_name":"International Stem Cell CORP","ticker":"ISCO","filing_date":"2026-09-08","form":"8-K","submitted_at":null,"items":[{"id":34985,"accession_number":"0001683168-26-007007","item_number":"2.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"International Stem Cell Corporation completed the sale of 100% of the membership interests of its wholly-owned subsidiary Lifeline Cell Technology, LLC to American Type Culture Collection, Inc. on September 1, 2026, for an adjusted purchase price of $25,250,000. This is a material disposition of a significant asset (a wholly-owned subsidiary) that would substantially affect the registrant's financial position and operations going forward, as evidenced by the pro forma financial statements showing elimination of LCT's substantial revenues and operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T20:05:11.418079+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":34985,"accession_number":"0001683168-26-007007","item_number":"2.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"International Stem Cell Corporation completed the sale of 100% of the membership interests of its wholly-owned subsidiary Lifeline Cell Technology, LLC to American Type Culture Collection, Inc. on September 1, 2026, for an adjusted purchase price of $25,250,000. This is a material disposition of a significant asset (a wholly-owned subsidiary) that would substantially affect the registrant's financial position and operations going forward, as evidenced by the pro forma financial statements showing elimination of LCT's substantial revenues and operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T20:05:11.418079+00:00","company_name":"International Stem Cell CORP","ticker":"ISCO","filing_date":"2026-09-08"}]}